Search
Search Term: hematology oncology
Research explores link between stem cell transplant, diabetes
Jan. 17, 2019—Brian Engelhardt is studying why as many as 50 percent of stem cell transplant recipients develop diabetes.
Hyundai Hope on Wheels keeps cancer research support rolling
Jun. 14, 2018—Debra Friedman, MD, director of the Division of Pediatric Hematology/Oncology, has been awarded a $100,000 Hyundai Hope on Wheels Impact Award. The grant was celebrated in a “handprint ceremony” with Hyundai representatives on June 12.
Jagasia to succeed Neuss as VICC Chief Medical Officer
Jun. 12, 2018—After successfully leading Vanderbilt-Ingram Cancer Center (VICC) through years of growth in patient volumes and enhanced care options, Michael Neuss, MD, Chief Medical Officer of the VICC Clinical Enterprise, is retiring as CMO. Neuss will be succeeded by Madan Jagasia, MBBS, MSCI, MMHC, who has been named to the George and Beverley Rawlings Directorship and is section chief, Hematology and Stem Cell Transplant and director of the Outpatient Stem Cell Clinic.
Faculty meeting recognizes excellence in education, research and clinical service
May. 24, 2018—During Wednesday’s Spring Faculty Meeting, Jeff Balser, M.D., Ph.D., dean of Vanderbilt University School of Medicine and President and CEO of Vanderbilt University Medical Center, highlighted the medical school’s rising stature among the country’s top-tier institutions.
Park named to VICC breast cancer leadership position
May. 17, 2018— Internationally renowned breast cancer expert Ben Ho Park, MD, PhD, has been named co-leader of the Breast Cancer Research Program, director of Precision Oncology and associate director for Translational Research at Vanderbilt-Ingram Cancer Center. In his academic role, he will serve as professor of Medicine. Park, who will assume his new post Sept. 1,...
Grant bolsters kidney cancer immunotherapy research
May. 10, 2018—W. Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer.
Six Vanderbilt physicians honored by medical societies
May. 3, 2018—Four faculty members of Vanderbilt University School of Medicine were among 78 physician-scientists inducted into The American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry. They are:
Children’s Hospital receives care quality award
May. 3, 2018—The Children’s Hospital Association (CHA) has recognized Monroe Carell Jr. Children’s Hospital at Vanderbilt with a Pediatric Quality Award.
Ware elected VP of clinical investigation society
Apr. 26, 2018—With last week’s election of Lorraine Ware, MD, as vice president of the American Society for Clinical Investigation (ASCI), two faculty members of the Vanderbilt University School of Medicine are among the current officers of the elite physician-scientist honor society.
VICC study sheds new light on Von Hippel-Lindau syndrome
Mar. 8, 2018—Investigators at Vanderbilt-Ingram Cancer Center (VICC) and the Virginia Tech Carilion Research Institute (VTCRI) have revealed a gene mutation’s role in Von Hippel-Lindau syndrome, a genetically inherited disease which causes tumor growth in several organs.
Children’s Hospital, Hunter’s Hope team to fight Krabbe disease
Mar. 8, 2018—Dylan May’s 6-month-old baby photo shows a smiling face and bright blue eyes — the appearance of a seemingly happy, healthy baby.
Directorships honor VUMC’s critical missions
Jan. 25, 2018—Vanderbilt University Medical Center (VUMC) on Monday held its first Directorship Celebration to honor and support eight of its leaders in clinical care, research, education and administration.